A lipid panel is not a verdict. It is a snapshot of how your body moves fat through the bloodstream — and every number on it means something different. What follows is the plain-language report: what each value is, what the targets are, how statins change them, and what to do about the ones that fall outside the range.
Cardiovascular risk is not defined by cholesterol alone. It is defined by the combination of lipid values, age, blood pressure, diabetes status, smoking history, and family history. A person with an LDL of 130 and no other risk factors faces a very different trajectory than a person with the same LDL who has already had a heart attack. The numbers matter — but only in context.
That said, the five primary analytes on a standard lipid panel carry specific weight. Here is what each one is measuring, and what range is considered optimal for a typical adult without existing cardiovascular disease.
| Analyte | Reference | Optimal | What it measures |
|---|---|---|---|
| Total cholesterol | < 200 mg/dL | TARGET | The sum of LDL, HDL, and one-fifth of triglycerides. A broad summary value. |
| LDL cholesterol | < 100 mg/dL ↑ | PRIORITY | The primary driver of atherosclerotic plaque. The main target of statin therapy. |
| HDL cholesterol | > 40 mg/dL (men) > 50 mg/dL (women) |
PROTECTIVE | Reverse cholesterol transport. Higher is generally better, though drug-raising does not improve outcomes. |
| Triglycerides | < 150 mg/dL | BORDERLINE | Circulating fat from diet and liver synthesis. Strongly influenced by sugar and alcohol intake. |
| Non-HDL cholesterol | < 130 mg/dL | USEFUL | Total minus HDL. Captures all atherogenic particles, including remnant cholesterol. |
| ApoB (secondary) | < 90 mg/dL | PRECISE | Counts the number of atherogenic particles directly. Sometimes more informative than LDL alone. |
| Lp(a) (once in a lifetime) | < 30 mg/dL | GENETIC | Genetically determined. Elevated Lp(a) is an independent risk factor that does not respond to statins. |
Targets are adjusted for risk. Someone who has already had a heart attack, stroke, or bypass often has an LDL goal below 70 mg/dL, and very high-risk patients are sometimes treated to below 55 mg/dL. That is not an arbitrary tightening of the number — it reflects the fact that the relationship between LDL and cardiovascular events is continuous and does not have a natural floor.
Statins are the most studied class of medication in cardiovascular medicine. Each one blocks HMG-CoA reductase, the rate-limiting enzyme in the liver's cholesterol synthesis pathway. The liver responds by pulling more LDL out of circulation. The magnitude of that response varies by molecule and dose — from roughly 20 percent LDL reduction on the weakest regimen to more than 55 percent on the strongest.
The statins below are listed by potency — the strength of their LDL-lowering effect at standard dosing. All are available as generics in the United States.
Atorvastatin 40–80 mg and rosuvastatin 20–40 mg produce the largest reductions in LDL — over 50 percent from baseline. Reserved for patients with established cardiovascular disease, diabetes with multiple risk factors, or very high LDL. Rosuvastatin is more hydrophilic than atorvastatin and is less affected by some drug interactions.
Simvastatin 20–40 mg, pravastatin 40–80 mg, and lovastatin 40 mg reduce LDL by 30 to 49 percent. Used for primary prevention in patients at intermediate risk. Simvastatin has more drug interactions and should be taken in the evening; pravastatin has the fewest interactions of the three.
Pitavastatin 1–2 mg and fluvastatin 20–40 mg reduce LDL by less than 30 percent. Sometimes chosen when a patient cannot tolerate higher-intensity statins or when the goal is modest lipid-lowering with minimal metabolic effects. Pitavastatin has a relatively favorable effect on blood sugar.
Ezetimibe blocks cholesterol absorption in the gut and lowers LDL by an additional 15–20 percent when added to a statin. Bempedoic acid works upstream in the same pathway as statins and is an option for statin-intolerant patients. PCSK9 inhibitors (evolocumab, alirocumab) are injectable antibodies that lower LDL by 50–60 percent but cost far more — typically reserved for familial hypercholesterolemia or very high risk.
Whichever statin you are on, the same tablet can cost five to ten times more at one licensed pharmacy than another. Before your next refill, compare the current price at two or three licensed U.S. sellers — a plain comparison like this trusted pharmacy comparison takes about two minutes and works for every generic on your list.
No class of medication is more discussed — or more misunderstood — than statins. The muscle aches that dominate online forums are real, but they are reported far more often than they are confirmed. In randomized, blinded trials, the difference in muscle symptoms between patients taking a statin and patients taking a placebo is small — on the order of 1 to 3 percent. That does not mean the symptoms are imaginary. It means the phenomenon is smaller than the internet suggests, and it means that trying a different statin, a lower dose, or an alternate-day schedule usually resolves the issue when it is real.
Three side effects matter clinically:
| Category | Frequency | What to know |
|---|---|---|
| Muscle aches (myalgia) | Common report | Usually reversible. Lower dose, different statin, or alternate-day dosing typically resolves it. Never ignore severe muscle pain with dark urine — that is a medical emergency. |
| Liver enzyme elevation | Uncommon | Routine monitoring is no longer recommended for most patients. Baseline and symptom-driven testing is enough. True liver injury is rare. |
| Blood sugar increase | Modest | Statins can slightly raise blood glucose and marginally increase diabetes diagnoses in high-risk patients. Cardiovascular benefit generally outweighs this. |
| Rhabdomyolysis | Rare | Severe muscle breakdown. Risk increases with high doses, certain drug interactions, and hypothyroidism. Seek immediate care for severe muscle pain with brown or dark urine. |
| New-onset diabetes (isolated) | Rare | Reported mainly with high-intensity statins. The cardiovascular benefit almost always exceeds the metabolic risk. |
Lifestyle is not an alternative to medication in high-risk patients — it is what makes the medication do more. Diet, exercise, and weight change also carry benefits statins do not: better blood pressure, better blood sugar, better sleep, better mood. The effects below are typical, not guaranteed — but every one of them has been demonstrated in randomized trials.
Reducing saturated fat to under 7% of daily calories lowers LDL meaningfully. Replacing it with unsaturated fat (olive oil, nuts, fish) is more effective than simply cutting fat.
Oats, barley, beans, lentils, apples, and psyllium husk bind cholesterol in the gut and increase its excretion. Fiber is one of the few interventions that also improves blood sugar and satiety.
150 minutes per week of moderate activity — walking, cycling, swimming — raises HDL modestly, lowers triglycerides, and improves how the body clears LDL particles. Consistency matters more than intensity.
Triglycerides respond more to sugar and refined carbohydrates than to fat. Reducing sweetened drinks alone can lower triglycerides dramatically in people with elevated levels.
For every kilogram of weight lost, LDL falls modestly and triglycerides fall more sharply. Even 5% weight loss improves the full lipid profile and reduces the severity of fatty liver, a common comorbidity.
Smoking lowers HDL, damages arterial walls, and accelerates atherosclerosis independently of cholesterol. Quitting reverses a substantial portion of this risk within the first year.
Every statin named on this page is available as a low-cost generic in the United States. Atorvastatin, rosuvastatin, simvastatin, and pravastatin — the four most commonly prescribed — are all produced by multiple manufacturers and priced well below their original brand versions. This is one of the few areas of American medicine where the drug itself is genuinely inexpensive.
What varies is not the pill — it is the price the pharmacy charges for it. The same atorvastatin 20 mg tablet, thirty-day supply, can sit at a five- to ten-fold spread between licensed U.S. sellers on the same afternoon. A live statin price comparison shows the current range in about two minutes, and the same logic applies to every generic on the panel above.
If you are starting an online refill for the first time, the process is documented step by step in this how to order prescriptions online guide — prescription first, licensed seller second, small first order third. And if you want a plain-language reference for how generics differ from brand-name drugs, this generic drug guide covers the FDA standard that makes the price difference rational, not suspicious.
Before you sign for a seller, verify them. A working VIPPS seal that resolves to a live record, a real U.S. street address, and a prescription requirement that cannot be waived. Pages like this one about Metformin4You are a good example of the transparency standard to expect — who runs the site, how sellers are selected, and what criteria are applied.
This report is aligned with public clinical guidance from the American Heart Association, the National Heart, Lung, and Blood Institute (NIH), and the U.S. Food and Drug Administration's BeSafeRx program. Drug label information draws on the National Library of Medicine's DailyMed database and MedlinePlus. Pharmacy verification follows the NABP VIPPS program.
The same generic tablet can cost five times more at one licensed pharmacy than another. A two-minute comparison across licensed U.S. sellers is the highest-yield habit you can add to a cardiovascular treatment plan — no prescription change required. Begin with the current Metformin price comparison as a live demonstration of how wide the spread runs.